Suppr超能文献

副干酪乳杆菌 SNB 来源后生元成分对肠道屏障功能障碍和肠道微生物组成的影响。

Effects of Lacticaseibacillus paracasei SNB-derived postbiotic components on intestinal barrier dysfunction and composition of gut microbiota.

机构信息

Sanya Institute of Nanjing Agricultural University, College of Food Science and Technology, Nanjing Agricultural University, Nanjing, Jiangsu 210095, PR China.

Jiangsu New-Bio Biotechnology Co., Ltd, Jiangyin, Jiangsu 214400, PR China; Jiangsu Biodep Biotechnology Co., Ltd, Jiangyin, Jiangsu 214400, PR China.

出版信息

Food Res Int. 2024 Jan;175:113773. doi: 10.1016/j.foodres.2023.113773. Epub 2023 Nov 25.

Abstract

The bacterial surface components are considered as effector molecules and show the potential to support intestinal health, but the detailed mechanism of how the gut microbiota changes after the intervention of surface molecules is still unknown. In the present study, capsular polysaccharide (B-CPS) and surface layer protein (B-SLP) were extracted from Lacticaseibacillus paracasei S-NB. The protective effect of direct administration of B-CPS (100 μg/mL) and B-SLP (100 μg/mL) on intestinal epithelial barrier dysfunction was verified based on the LPS-induced Caco-2 cell model. Additionally, the B-CPS and B-SLP could be utilized as carbon source and nitrogen source for the growth of several Lactobacillus strains, respectively. The postbiotic potential of B-CPS and B-SLP was further evaluated by in vitro fermentation with fecal cultures. The B-CPS and a combination of B-CPS and B-SLP regulated the composition of gut microbiota by increasing the relative abundances of Bacteroides, Bifidobacterium, Phascolarctobacterium, Parabacteroides, Subdoligranulum and Collinsella and decreasing the abundance of pathogenic bacteria like Escherichia-Shigella, Blautia, Citrobacter and Fusobacterium. Meanwhile, the total short-chain fatty acid production markedly increased after fermentation with either B-CPS individually or in combination with B-SLP. These results provided an important basis for the application of B-CPS and B-SLP as postbiotics to improve human intestinal health.

摘要

细菌表面成分被认为是效应分子,具有支持肠道健康的潜力,但肠道微生物群在干预表面分子后如何变化的详细机制仍不清楚。本研究从副干酪乳杆菌 S-NB 中提取了荚膜多糖(B-CPS)和表面层蛋白(B-SLP)。基于 LPS 诱导的 Caco-2 细胞模型,验证了直接给予 B-CPS(100 μg/mL)和 B-SLP(100 μg/mL)对肠上皮屏障功能障碍的保护作用。此外,B-CPS 和 B-SLP 可分别作为几种乳杆菌生长的碳源和氮源。通过粪便培养的体外发酵进一步评估了 B-CPS 和 B-SLP 的后生潜力。B-CPS 和 B-CPS 与 B-SLP 的组合通过增加拟杆菌属、双歧杆菌属、粪拟杆菌属、副拟杆菌属、副真杆菌属和柯林斯氏菌属的相对丰度,降低了致病性细菌如大肠杆菌-志贺氏菌属、布劳特氏菌属、柠檬酸杆菌属和梭杆菌属的丰度,从而调节了肠道微生物群的组成。同时,单独使用 B-CPS 或与 B-SLP 联合使用后,总短链脂肪酸的产生明显增加。这些结果为 B-CPS 和 B-SLP 作为后生元改善人类肠道健康的应用提供了重要依据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验